Total Payments
$1,350
2022 Payments
$133.90
Companies
8
Transactions
23
Medicare Patients
2,211
Medicare Billing
$527,128
Payment Breakdown by Category
Food & Beverage$1,350 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,350 | 23 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $343.39 | 9 | $0 (2018) |
| Lilly USA, LLC | $269.83 | 4 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $258.89 | 5 | $0 (2022) |
| Janssen Scientific Affairs, LLC | $124.98 | 1 | $0 (2021) |
| PFIZER INC. | $118.93 | 1 | $0 (2019) |
| AbbVie, Inc. | $118.71 | 1 | $0 (2019) |
| Alexion Pharmaceuticals, Inc. | $103.38 | 1 | $0 (2018) |
| GlaxoSmithKline, LLC. | $11.68 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $133.90 | 4 | AstraZeneca Pharmaceuticals LP ($133.90) |
| 2021 | $249.97 | 2 | AstraZeneca Pharmaceuticals LP ($124.99) |
| 2019 | $306.38 | 4 | PFIZER INC. ($118.93) |
| 2018 | $441.14 | 5 | Lilly USA, LLC ($201.09) |
| 2017 | $218.40 | 8 | Celgene Corporation ($206.72) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/27/2022 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 05/27/2022 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $1.04 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 03/04/2022 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 03/03/2022 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $90.00 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 11/10/2021 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 10/07/2021 | Janssen Scientific Affairs, LLC | SIMPONI ARIA (Biological), STELARA, TREMFYA | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: Immunology | ||||||
| 10/16/2019 | AbbVie, Inc. | Rinvoq (Biological) | Food and Beverage | In-kind items and services | $118.71 | General |
| Category: Immunology | ||||||
| 07/11/2019 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $56.81 | General |
| Category: Immunology | ||||||
| 07/11/2019 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: Immunology | ||||||
| 04/17/2019 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $118.93 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/15/2018 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Drug) | Food and Beverage | In-kind items and services | $103.38 | General |
| Category: Immunology | ||||||
| 08/29/2018 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $76.09 | General |
| 07/25/2018 | Celgene Corporation | Otezla (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Dermatology | ||||||
| 03/14/2018 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Immunology | ||||||
| 01/11/2018 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $11.67 | General |
| 11/20/2017 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $20.68 | General |
| 10/12/2017 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $4.91 | General |
| 09/11/2017 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $21.45 | General |
| 08/24/2017 | Celgene Corporation | Otezla (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Dermatology | ||||||
| 07/26/2017 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $11.68 | General |
| Category: IMMUNOLOGY | ||||||
| 06/05/2017 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $14.32 | General |
| 04/24/2017 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $6.99 | General |
| 02/06/2017 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $13.37 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 7 | 341 | 13,739 | $554,993 | $95,765 |
| 2021 | 13 | 943 | 38,905 | $1.2M | $328,158 |
| 2020 | 14 | 927 | 3,723 | $298,632 | $103,205 |
Total Patients
2,211
Total Services
56,367
Medicare Billing
$527,128
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2022 | 11 | 12,200 | $414,800 | $57,109 | 13.8% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 17 | 1,020 | $49,020 | $16,614 | 33.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 102 | 112 | $39,200 | $10,382 | 26.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 120 | 135 | $33,345 | $8,291 | 24.9% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 28 | 36 | $11,034 | $2,332 | 21.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 30 | 73 | $5,475 | $914.92 | 16.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 33 | 163 | $2,119 | $121.57 | 5.7% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2021 | 20 | 33,800 | $850,000 | $190,222 | 22.4% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 38 | 3,060 | $125,460 | $49,677 | 39.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 223 | 347 | $79,215 | $36,729 | 46.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 231 | 349 | $56,106 | $24,626 | 43.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 75 | 75 | $25,381 | $10,346 | 40.8% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 84 | 133 | $41,879 | $7,784 | 18.6% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 58 | 217 | $17,503 | $2,715 | 15.5% |
| 20550 | Injections of tendon sheath, ligament, or muscle membrane | Office | 2021 | 35 | 42 | $9,831 | $2,083 | 21.2% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 17 | 21 | $2,066 | $942.78 | 45.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 14 | 14 | $2,416 | $866.20 | 35.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 120 | 814 | $10,582 | $811.65 | 7.7% |
| 20600 | Aspiration and/or injection of small joint or joint capsule | Office | 2021 | 16 | 17 | $3,501 | $758.26 | 21.7% |
| 20605 | Aspiration and/or injection of medium joint or joint capsule | Office | 2021 | 12 | 16 | $3,579 | $598.60 | 16.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 265 | 410 | $81,180 | $34,104 | 42.0% |
| J0897 | Injection, denosumab, 1 mg | Office | 2020 | 23 | 1,800 | $73,800 | $28,195 | 38.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 160 | 208 | $27,618 | $11,780 | 42.7% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2020 | 83 | 121 | $39,164 | $6,548 | 16.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 46 | 46 | $13,938 | $6,141 | 44.1% |
About Dr. David Trock, M.D
Dr. David Trock, M.D is a Rheumatology healthcare provider based in Danbury, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1942229216.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Trock, M.D has received a total of $1,350 in payments from pharmaceutical and medical device companies, with $133.90 received in 2022. These payments were reported across 23 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($1,350).
As a Medicare-enrolled provider, Trock has provided services to 2,211 Medicare beneficiaries, totaling 56,367 services with total Medicare billing of $527,128. Data is available for 3 years (2020–2022), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Danbury, CT
- Active Since 07/18/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1942229216
Products in Payments
- SAPHNELO (Biological) $258.89
- Otezla (Drug) $250.00
- TALTZ (Drug) $193.74
- SIMPONI ARIA (Biological) $124.98
- XELJANZ (Drug) $118.93
- Rinvoq (Biological) $118.71
- SOLIRIS (Drug) $103.38
- BENLYSTA (Biological) $11.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Danbury
Dr. Michael Spiegel, M.d, M.D
Rheumatology — Payments: $304,296
Rheumatology $304,296
Richard Roseff, Md, MD
Rheumatology — Payments: $99,412
Rheumatology $99,412
Alla Rudinskaya, M.d, M.D
Rheumatology — Payments: $2,099
Rheumatology $2,099
Jesse Dabit, Md, MD
Rheumatology — Payments: $670.34
Rheumatology $670.34
Anne Liebling, Md, MD
Rheumatology — Payments: $125.00
Rheumatology $125.00
Dr. Kenneth Miller, Md, MD
Rheumatology
Rheumatology